Joseph A Akers - Net Worth and Insider Trading

Joseph A Akers Net Worth

The estimated net worth of Joseph A Akers is at least $260 dollars as of 2024-11-13. Joseph A Akers is the Director of Titan Pharmaceuticals Inc and owns about 59 shares of Titan Pharmaceuticals Inc (TTNP) stock worth over $260. Details can be seen in Joseph A Akers's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph A Akers has not made any transactions after 2018-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joseph A Akers

To

Joseph A Akers Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph A Akers owns 1 companies in total, including Titan Pharmaceuticals Inc (TTNP) .

Click here to see the complete history of Joseph A Akers’s form 4 insider trades.

Insider Ownership Summary of Joseph A Akers

Ticker Comapny Transaction Date Type of Owner
TTNP Titan Pharmaceuticals Inc 2021-02-10 director

Joseph A Akers Latest Holdings Summary

Joseph A Akers currently owns a total of 1 stock. Joseph A Akers owns 59 shares of Titan Pharmaceuticals Inc (TTNP) as of September 21, 2018, with a value of $260.

Latest Holdings of Joseph A Akers

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TTNP Titan Pharmaceuticals Inc 2018-09-21 59 4.42 260

Holding Weightings of Joseph A Akers


Joseph A Akers Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph A Akers has made a total of 0 transactions in Titan Pharmaceuticals Inc (TTNP) over the past 5 years. The most-recent trade in Titan Pharmaceuticals Inc is the acquisition of 56 shares on September 21, 2018, which cost Joseph A Akers around $50,000.

Insider Trading History of Joseph A Akers

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph A Akers Trading Performance

GuruFocus tracks the stock performance after each of Joseph A Akers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph A Akers is 5.46%. GuruFocus also compares Joseph A Akers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph A Akers within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph A Akers's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph A Akers

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 42.62 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 44.92 LIMIT LIMIT LIMIT LIMIT LIMIT

Joseph A Akers Ownership Network

Ownership Network List of Joseph A Akers

No Data

Ownership Network Relation of Joseph A Akers

Insider Network Chart

Joseph A Akers Owned Company Details

What does Titan Pharmaceuticals Inc do?

Who are the key executives at Titan Pharmaceuticals Inc?

Joseph A Akers is the director of Titan Pharmaceuticals Inc. Other key executives at Titan Pharmaceuticals Inc include 10 percent owner Seow Gim Shen , 10 percent owner Sire Group Ltd. , and director & President and COO Katherine Beebe .

Titan Pharmaceuticals Inc (TTNP) Insider Trades Summary

Over the past 18 months, Joseph A Akers made no insider transaction in Titan Pharmaceuticals Inc (TTNP). Other recent insider transactions involving Titan Pharmaceuticals Inc (TTNP) include a net sale of 7,495,936 shares made by David E. Lazar ,

In summary, during the past 3 months, insiders sold 0 shares of Titan Pharmaceuticals Inc (TTNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 374,797 shares of Titan Pharmaceuticals Inc (TTNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 374,797 shares.

Titan Pharmaceuticals Inc (TTNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Titan Pharmaceuticals Inc Insider Transactions

No Available Data

Joseph A Akers Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph A Akers. You might contact Joseph A Akers via mailing address: 630 Fifth Avenue, 22nd Floor, New York Ny 10111.